113 related articles for article (PubMed ID: 30728908)
21. PANC-1 cells proliferative response to ionizing radiation is related to GSK-3β phosphorylation.
Mohamad NA; Cricco GP; Cocca CM; Rivera ES; Bergoc RM; Martín GA
Biochem Cell Biol; 2012 Dec; 90(6):779-90. PubMed ID: 23194191
[TBL] [Abstract][Full Text] [Related]
22. HBD3 Induces PD-L1 Expression on Head and Neck Squamous Cell Carcinoma Cell Lines.
Gomez Hernandez MP; Bates AM; Starman EE; Lanzel EA; Comnick C; Xie XJ; Brogden KA
Antibiotics (Basel); 2019 Sep; 8(4):. PubMed ID: 31554151
[TBL] [Abstract][Full Text] [Related]
23. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.
Tan J; Geng L; Yazlovitskaya EM; Hallahan DE
Cancer Res; 2006 Feb; 66(4):2320-7. PubMed ID: 16489037
[TBL] [Abstract][Full Text] [Related]
25. A comparison of cell survival and heat shock protein expression after radiation in normal dermal fibroblasts, microvascular endothelial cells, and different head and neck squamous carcinoma cell lines.
Muschter D; Geyer F; Bauer R; Ettl T; Schreml S; Haubner F
Clin Oral Investig; 2018 Jul; 22(6):2251-2262. PubMed ID: 29307045
[TBL] [Abstract][Full Text] [Related]
26. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.
Kim HR; Ha SJ; Hong MH; Heo SJ; Koh YW; Choi EC; Kim EK; Pyo KH; Jung I; Seo D; Choi J; Cho BC; Yoon SO
Sci Rep; 2016 Nov; 6():36956. PubMed ID: 27841362
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
[TBL] [Abstract][Full Text] [Related]
29. PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma.
Yu GT; Bu LL; Huang CF; Zhang WF; Chen WJ; Gutkind JS; Kulkarni AB; Sun ZJ
Oncotarget; 2015 Dec; 6(39):42067-80. PubMed ID: 26573233
[TBL] [Abstract][Full Text] [Related]
30. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
[TBL] [Abstract][Full Text] [Related]
31. [Current events in immunotherapy for upper aerodigestive tract cancer].
Outh-Gauer S; Le Tourneau C; Broudin C; Scotte F; Roussel H; Hans S; Mandavit M; Tartour E; Badoual C
Ann Pathol; 2017 Feb; 37(1):79-89. PubMed ID: 28111039
[TBL] [Abstract][Full Text] [Related]
32. Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.
Black M; Barsoum IB; Truesdell P; Cotechini T; Macdonald-Goodfellow SK; Petroff M; Siemens DR; Koti M; Craig AW; Graham CH
Oncotarget; 2016 Mar; 7(9):10557-67. PubMed ID: 26859684
[TBL] [Abstract][Full Text] [Related]
33. Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay.
Scorer P; Scott M; Lawson N; Ratcliffe MJ; Barker C; Rebelatto MC; Walker J
Diagn Pathol; 2018 Jul; 13(1):47. PubMed ID: 30041679
[TBL] [Abstract][Full Text] [Related]
34. Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway.
Shen MJ; Xu LJ; Yang L; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
Oncotarget; 2017 Oct; 8(46):80506-80520. PubMed ID: 29113321
[TBL] [Abstract][Full Text] [Related]
35. LPLI inhibits apoptosis upstream of Bax translocation via a GSK-3beta-inactivation mechanism.
Zhang L; Zhang Y; Xing D
J Cell Physiol; 2010 Jul; 224(1):218-28. PubMed ID: 20333643
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
37. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
38. The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Balermpas P; Rödel F; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Sak A; Stuschke M; Gkika E; Grosu AL; Abdollahi A; Debus J; Stangl S; Ganswindt U; Belka C; Pigorsch S; Multhoff G; Combs SE; Welz S; Zips D; Lim SY; Rödel C; Fokas E;
Int J Cancer; 2017 Aug; 141(3):594-603. PubMed ID: 28480996
[TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
40. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.
Pulkkinen JO; Servomaa K; Pekkola K; Kulmala J; Grenman R
Anticancer Res; 2000; 20(3A):1503-11. PubMed ID: 10928063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
